Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy


Episode Artwork
1.0x
0% played 00:00 00:00
Jan 30 2025 11 mins   12

Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD.

Related Content: